Penserra Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
6
-885
| -99% | -$148K | ﹤0.01% | 1014 |
|
|
2025
Q1 | $199K | Buy |
891
+137
| +18% | +$30.6K | ﹤0.01% | 738 |
|
|
2024
Q4 | $245K | Buy |
754
+144
| +24% | +$46.8K | ﹤0.01% | 708 |
|
|
2024
Q3 | $182K | Buy |
610
+143
| +31% | +$42.7K | ﹤0.01% | 716 |
|
|
2024
Q2 | $154K | Buy |
467
+461
| +7,683% | +$152K | ﹤0.01% | 768 |
|
|
2024
Q1 | $2K | Sell |
6
-337
| -98% | -$112K | ﹤0.01% | 1153 |
|
|
2023
Q4 | $120K | Sell |
343
-71
| -17% | -$24.8K | ﹤0.01% | 870 |
|
|
2023
Q3 | $155K | Sell |
414
-68
| -14% | -$25.5K | ﹤0.01% | 809 |
|
|
2023
Q2 | $183K | Buy |
482
+478
| +11,950% | +$181K | ﹤0.01% | 816 |
|
|
2023
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 1088 |
|
|
2022
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1234 |
|
|
2022
Q1 | – | Sell |
-17,964
| Closed | -$8.43M | – | 1499 |
|
|
2021
Q4 | $8.43M | Buy |
17,964
+11,466
| +176% | +$5.38M | 0.18% | 153 |
|
|
2021
Q3 | $2.76M | Buy |
+6,498
| New | +$2.76M | 0.06% | 306 |
|
|
2021
Q1 | – | Sell |
-8,144
| Closed | -$2.31M | – | 1146 |
|
|
2020
Q4 | $2.31M | Sell |
8,144
-16,938
| -68% | -$4.8M | 0.05% | 250 |
|
|
2020
Q3 | $6.9M | Buy |
25,082
+24,072
| +2,383% | +$6.62M | 0.26% | 100 |
|
|
2020
Q2 | $229K | Sell |
1,010
-530
| -34% | -$120K | 0.01% | 464 |
|
|
2020
Q1 | $308K | Buy |
+1,540
| New | +$308K | 0.02% | 397 |
|